A recent study demonstrated that the inactivation of tumor suppressors (Tp53, Nf1, and Pten) in mouse oligodendrocyte-lineage cells (OLCs) versus NSC (NSCs) generated glioblastoma with distinct phenotypes and therapeutic vulnerabilities (Wang et al, 2020). Here, TP53 is linked to glioblastoma.